Our team

In October we support Breast Cancer Awareness Month

Did you know breast cancer is the most common cancer in women? At MSD, we show solidarity with those facing breast cancer and do everything we can to support further advances to help fighting the disease. Especially during Breast Cancer Awareness Month October we support various activities to educate about the importance of prevention and early detection. Learn more about our commitment.

30.10.2025

Share this article

Facebook icon

.st0{fill:#00857C;} X icon

Linkedin icon

Email icon

Banner: MSD supports Breast Cancer Awareness Month October

In Switzerland, around 6,600 women and 60 men are diagnosed with breast cancer every year. Although new therapies have improved the prognosis of patients with breast cancer, around 1400 women still die from the disease in Switzerland every year.

“We stand united for the mothers, sisters, daughters and loved ones impacted by breast cancer and do everything we can to drive further innovation to help save and improve lives.”

As with many other cancers, the earlier breast cancer is detected, the better the chances of a cure. That’s why we support various initiatives to raise awareness!

Awareness campaign in the Pink Cube

In October, we are supporting the awareness campaign “PINK CUBE Test Your Breast” together with EUROPA DONNA Switzerland, the Swiss Cancer League, and many other sponsors.

The pink container “Pink Cube” travels through 11 cantons, where gynecologists will offer interested visitors free consultations and breast examinations. Everyone is invited to visit the Pink Cube.

Find out more here

Banner: website about breast cancer

Website about breast cancer

Our patient portal, MSD Gesundheit, contains detailed information about breast cancer, including risks and options for prevention, early detection and treatment of breast cancer.

In addition, the website offers answers to the most frequently asked questions about breast cancer and information on where affected people can get advice and support.

Visit the MSD Patient Portal

Pink Ribbon Charity Walk

A special moment for us! Every year, more than 50 colleagues take part in the Pink Ribbon Charity Walk as Team MSD Switzerland. 

The solidarity walk celebrates survivors, remembers those that we have lost, raises awareness, and much-needed funds to work towards the vision of zero deaths from breast cancer.

MSD employees at the Pink Ribbon Charity Walk

Facts about breast cancer you should know

Breast cancer is the most common cancer in women, accounting for nearly one-third of all cancer diagnoses. In Switzerland, about 6,600 women and 60 men are diagnosed with breast cancer every year and around 1,400 women die from it each year. The rate of disease increases with age. Nevertheless, one in five women is younger than 50 at the time of diagnosis. Mammography is the most important examination for the early detection of breast cancer. It can reveal a tumor before it can be felt or causes any symptoms. Medical societies and the Cancer League recommend that women aged 50 and over have a mammogram every two years. Regular self-examination of the breasts also helps women become more familiar with their bodies and notice any changes that should be checked by a doctor.

The earlier breast cancer is detected and treated, the better the chances of cure. That’s the message we want to get across to everyone!

About our clinical research in Oncology

Did you know that MSD operates one of the world’s largest and fastest growing clinical research programs in oncology? It currently includes more than 1,600 clinical trials. Switzerland is part of this research program. Our team currently coordinates 36 clinical trials in different tumor types (as of 10/2025). MSD is also one of the leading companies in the research of vaccines against preventable diseases, such as cervical cancer and other HPV-related cancers. In Switzerland, we collaborate with various partners to advance innovative solutions in cancer treatment. In recent years, we have made an important contribution to improving treatment options for cancer patients.

Find out more about our work here.


CH-NON-01897, 10/2025